Six novel minimally invasive therapies for benign prostatic hyperplasia / 浙江大学学报·医学版
Journal of Zhejiang University. Medical sciences
;
(6): 162-168, 2023.
Artigo
em Inglês
| WPRIM
| ID: wpr-982031
ABSTRACT
Benign prostatic hyperplasia (BPH) is the most common cause of lower urinary tract symptoms in men. When drug treatment is ineffective or conventional surgery is not suitable, novel minimally invasive therapies can be considered. These include prostatic urethral lift, prostatic artery embolisation, water vapor thermal therapy, Aquablation-image guided robotic waterjet ablation, temporary implantable nitinol device and prostatic stents. These novel therapies can be performed in outpatient setting under local anesthesia, with shorter operative and recovery times, and better protection of ejaculatory function and erectile function. General conditions of the patient and advantages and disadvantages of the each of these therapies should be fully considered to make individualized plans.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Hiperplasia Prostática
/
Stents
/
Resultado do Tratamento
/
Procedimentos Cirúrgicos Minimamente Invasivos
/
Embolização Terapêutica
/
Sintomas do Trato Urinário Inferior
Limite:
Humanos
/
Masculino
Idioma:
Inglês
Revista:
Journal of Zhejiang University. Medical sciences
Ano de publicação:
2023
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS